CRIS - CurisAbout Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $9.99 | Open | |
| Volume | Market Cap | 604.06M | |
| Yield | Last Dividend |
| Curis to Present at B. Riley Securities ... | 01/14/21 |
| LEXINGTON, Mass., Jan. 14, 2021 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeut... | |
| The Daily Biotech Pulse: GSK, Vir To Sta... | 01/12/21 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 11) 10X... | |
| The Daily Biotech Pulse: Aerpio Reviews ... | 01/06/21 |
| Here???s a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 5) Cu... | |
| The Daily Biotech Pulse: Aerpio Reviews ... | 01/06/21 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 5) Curi... | |
| Curis to Present at H.C. Wainwright & Co... | 01/05/21 |
| /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer,... | |
| The Daily Biotech Pulse: FDA Nod For Amp... | 12/29/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Dec. 28) Acl... | |
| Curis Announces Closing of Public Offeri... | 12/14/20 |
| LEXINGTON, Mass., Dec. 14, 2020 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeut... | |
| The Hits Keep Coming With Curis???s Seco... | 12/09/20 |
| No summary available. | |
| Curis Announces Pricing of Public Offeri... | 12/09/20 |
| LEXINGTON, Mass., Dec. 9, 2020 /PRNewswire/ -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development of innovative therapeutic... | |
| 71 Biggest Movers From Yesterday | 12/09/20 |
| Gainers Curis, Inc. (NASDAQ: CRIS ) stock climbed 354.9% to close at $6.55 on Tuesday after the company announced "positive" preliminary data from an ... | |
| Curis Announces Proposed Public Offering... | 12/08/20 |
| /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer,... | |
| Curis Surges 330% On Early Stage Blood C... | 12/08/20 |
| Curis, Inc. (NASDAQ: CRIS ) shares were skyrocketing Tuesday on above-average volume after the company announced updated Phase 1 data on its investiga... | |
| Curis Announces Positive Preliminary Dat... | 12/08/20 |
| LEXINGTON, Mass., Dec. 8, 2020 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeuti... | |
| Curis Announces Updated Preliminary Data... | 12/07/20 |
| LEXINGTON, Mass. , Dec. 7, 2020 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS ), a biotechnology company focused on the development of innovative therapeu... | |
| Curis to Host Virtual Event to Discuss C... | 12/02/20 |
| LEXINGTON, Mass., Dec. 2, 2020 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeuti... | |
| Curis, Inc. to Host Earnings Name | 11/10/20 |
| Curis, Inc. to Host Earnings Name - | |
| Curis Reports Third Quarter 2020 Financi... | 11/10/20 |
| LEXINGTON, Mass., Nov. 10, 2020 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeut... | |
| Curis Announces Collaboration with the N... | 11/10/20 |
| /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer,... | |
| The Week Ahead In Biotech: Supernus, San... | 11/08/20 |
| Biotech stocks turned around with the broader market in the week ended Nov. 6, as investors warmed to the idea of a split Congress and a change of gua... | |
| Curis Announces Three Abstracts for CA-4... | 11/04/20 |
| LEXINGTON, Mass., Nov. 4, 2020 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeuti... | |
| Curis to Present at H.C. Wainwright & Co... | 11/04/20 |
| LEXINGTON, Mass., Nov. 4, 2020 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeuti... | |
| Curis Earnings Report: Here???s what to ... | 11/03/20 |
| Curis announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by??? | |
| Curis to Release Third Quarter 2020 Fina... | 11/02/20 |
| LEXINGTON, Mass. , Nov. 2, 2020 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS ), a biotechnology company focused on the development of innovative therapeu... | |
| Curis Highlights Publication in ACS Medi... | 10/21/20 |
| LEXINGTON, Mass., Oct. 21, 2020 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeut... | |
| Curis Announces Abstract for CI-8993 Acc... | 10/14/20 |
| LEXINGTON, Mass. , Oct. 14, 2020 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS ), a biotechnology company focused on the development of innovative therape... | |
| Curis to Present at Upcoming Investor Co... | 09/10/20 |
| LEXINGTON, Mass. , Sept. 10, 2020 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS ), a biotechnology company focused on the development of innovative therap... | |
| Soon, you can get your train tickets ver... | 07/23/20 |
| The Centre of Railway Information System (CRIS), an IT arm of IRCTC, has rolled out the application, which was developed by the Prayagraj division of ... | |
| Curis Announces $17.5 Million Registered... | 06/11/20 |
| LEXINGTON, Mass., June 11, 2020 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeut... | |
| The 'Important Step' For Nano-Cap Biopha... | 06/10/20 |
| Shares of nano-cap biopharma Curis, Inc. (NASDAQ: CRIS ) are on a strong two-day run that has lifted the equity from penny stock territory. What Happe... | |
| Why the FDA Is Pushing Curis Stock So Mu... | 06/10/20 |
| No summary available. | |
| Buy rating | 01/15/21 |
| HC Wainwright & Co. maintains Buy rating and raises Price Target from $9.00 to $16.00 | |
| Buy rating | 12/08/20 |
| HC Wainwright & Co. maintains Buy rating and raises Price Target from $5.00 to $9.00 | |
| Buy rating | 11/24/20 |
| HC Wainwright & Co. initiates coverage with Buy rating and announces Price Target of $5.00 | |
| Date | 2020-11-10 (AMC) | Est. (EPS/Rev.) | ($0.13)/ 2.57M |
| Actual (EPS/Rev.) | $-0.11/ $2.74 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Trading Systems | Trading Systems | 83.00 % | Subscribe |
| WIDE AWAKE | JOHN KROLIKOWSKI JR | 80.00 % | Follow |
| Swing Trading Cheap Stocks <~ $10 | Michael S. DeVries | 67.00 % | Follow |
| BLOWBACK | JOHN KROLIKOWSKI JR | 39.00 % | Follow |
| OG | AL GORE RHYTHMS | 35.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
